BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26518486)

  • 21. Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis.
    Pinto RS; Machado UF; Passarelli M
    Biomark Med; 2020 Jun; 14(8):611-614. PubMed ID: 32530293
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of mass spectrometry in studies of glycation processes and diabetes management.
    D'Aronco S; Crotti S; Agostini M; Traldi P; Chilelli NC; Lapolla A
    Mass Spectrom Rev; 2019 Jan; 38(1):112-146. PubMed ID: 30423209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between acute respiratory failure requiring mechanical ventilation and the production of advanced glycation end products.
    Edriss H; Molehin AJ; Gavidia R; Selvan K; Nugent K
    J Investig Med; 2020 Oct; 68(7):1235-1240. PubMed ID: 32859644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation of advanced glycation end products in the skin is accelerated in relation to insulin resistance in people with Type 1 diabetes mellitus.
    Uruska A; Gandecka A; Araszkiewicz A; Zozulinska-Ziolkiewicz D
    Diabet Med; 2019 May; 36(5):620-625. PubMed ID: 30706538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advanced glycation end product (AGE) modified proteins in tears of diabetic patients.
    Zhao Z; Liu J; Shi B; He S; Yao X; Willcox MD
    Mol Vis; 2010 Aug; 16():1576-84. PubMed ID: 20806041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men.
    Lamb LS; Alfonso H; Norman PE; Davis TME; Forbes J; Müench G; Irrgang F; Almeida OP; Golledge J; Hankey GJ; Flicker L; Yeap BB
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4224-4231. PubMed ID: 30137355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HbA1c: a useful cardiovascular risk marker in those without diabetes?
    Preiss D; Sattar N
    Diabetologia; 2010 Dec; 53(12):2468-9. PubMed ID: 20835700
    [No Abstract]   [Full Text] [Related]  

  • 28. Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes.
    Wannamethee SG; Welsh P; Papacosta O; Ellins EA; Halcox JPJ; Whincup PH; Sattar N
    Atherosclerosis; 2017 Sep; 264():36-43. PubMed ID: 28759844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diabetes: 8 strategies to put into practice.
    Adler RN; Harlan DM;
    J Fam Pract; 2013 Oct; 62(10):542-7. PubMed ID: 24143345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Non-enzymatic glycation of proteins: from diabetes to cancer].
    Ansari NA; Rasheed Z
    Biomed Khim; 2010; 56(2):168-78. PubMed ID: 21341505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycated haemoglobin: what is the diagnostic yield at shortened testing intervals?
    Loh TP; Tan KM; Saw S; Sethi SK
    Diabetes Res Clin Pract; 2011 Nov; 94(2):e40-2. PubMed ID: 21840616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycated nail proteins as a new biomarker in management of the South Kivu Congolese diabetics.
    Katchunga PB; Mirindi PN; Kishabongo AS; Cikomola JC; Bwanamdogo S; Philippé J; Speeckaert MM; Delanghe JR
    Biochem Med (Zagreb); 2015; 25(3):469-73. PubMed ID: 26526975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycation as the glucose link to diabetic complications.
    Gugliucci A
    J Am Osteopath Assoc; 2000 Oct; 100(10):621-34. PubMed ID: 11105451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemoglobin A
    Chan CL; Hope E; Thurston J; Vigers T; Pyle L; Zeitler PS; Nadeau KJ
    Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycated albumin versus glycated hemoglobin as glycemic indicator in hemodialysis patients with diabetes mellitus: variables that influence.
    Sany D; Elshahawy Y; Anwar W
    Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):260-73. PubMed ID: 23538348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The challenges of measuring glycemic variability.
    Rodbard D
    J Diabetes Sci Technol; 2012 May; 6(3):712-5. PubMed ID: 22768904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reference interval determination for glycated albumin in defined subgroups of a South African population.
    Matsha TE; Korf M; Erasmus RT; Hoffmann M; Mapfumo C; Smit F; Zemlin AE
    Ann Clin Biochem; 2019 Jul; 56(4):480-487. PubMed ID: 31037956
    [No Abstract]   [Full Text] [Related]  

  • 38. [Problematic issues for diagnosis of diabetes mellitus in the elderly].
    Fujisawa T; Ikegami H; Ogihara T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():740-5. PubMed ID: 12387078
    [No Abstract]   [Full Text] [Related]  

  • 39. HONE IN ON THE RANGE.
    Scheiner G
    Diabetes Self Manag; 2015; 32(4):18-20, 23. PubMed ID: 26380396
    [No Abstract]   [Full Text] [Related]  

  • 40. Arthroplasty in veterans: analysis of cartilage, bone, serum, and synovial fluid reveals differences and similarities in osteoarthritis with and without comorbid diabetes.
    Oren TW; Botolin S; Williams A; Bucknell A; King KB
    J Rehabil Res Dev; 2011; 48(10):1195-210. PubMed ID: 22234664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.